DYSPORT clostridium botulinum type A toxin Australia - English - Department of Health (Therapeutic Goods Administration)

dysport clostridium botulinum type a toxin

ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 300 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)

Nuceiva European Union - English - EMA (European Medicines Agency)

nuceiva

evolus pharma b.v. - botulinum toxin type a - skin aging - other muscle relaxants, peripherally acting agents - temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines), when the severity of the above facial lines has an important psychological impact in adults below 65 years of age.

BOCOUTURE 50 units powder for solution for injection Malta - English - Medicines Authority

bocouture 50 units powder for solution for injection

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 50 u - muscle relaxants

BOCOUTURE 100 units powder for solution for injection Malta - English - Medicines Authority

bocouture 100 units powder for solution for injection

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 100 u - muscle relaxants

Botox 100 Allergan Units Powder for solution for injection Malta - English - Medicines Authority

botox 100 allergan units powder for solution for injection

allergan pharmaceuticals ireland castlebar road, westport, county mayo, ireland - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 100 allergan units/0.1 millilitre - muscle relaxants

Botox 50 Allergan Units Powder for solution for injection Malta - English - Medicines Authority

botox 50 allergan units powder for solution for injection

allergan pharmaceuticals ireland castlebar road, westport, county mayo, ireland - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 50 allergan units/0.1 millilitre - muscle relaxants

BOTOX 200 Allergan Units Powder for solution for injection Malta - English - Medicines Authority

botox 200 allergan units powder for solution for injection

allergan pharmaceuticals ireland castlebar road, westport, county mayo, ireland - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 200 allergan units/0.1 millilitre - muscle relaxants

Vistabel 4 Allergan Units/0.1ml, powder for solution for injection Malta - English - Medicines Authority

vistabel 4 allergan units/0.1ml, powder for solution for injection

allergan pharmaceuticals ireland castlebar road, westport, county mayo, ireland - botulinum toxin, type a - powder for solution for injection - botulinum toxin type a 4 allergan units/0.1 millilitre - muscle relaxants

Botox New Zealand - English - Medsafe (Medicines Safety Authority)

botox

abbvie limited - botulinum toxin type a 50 u - powder for injection - 50 u - active: botulinum toxin type a 50 u excipient: albumin sodium chloride - · for the prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month with headache lasting 4 hours a day or longer, of which at least 8 days are with migraine)

Botox® New Zealand - English - Medsafe (Medicines Safety Authority)

botox®

abbvie limited - botulinum toxin type a 200 u - powder for injection - 200 u - active: botulinum toxin type a 200 u excipient: albumin sodium chloride - · the treatment of urinary incontinence due to neurogenic detrusor overactivity (eg. spinal cord injury or multiple sclerosis) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.